Table 1

Clinical features of affected individuals with biallelic ATP9A pathogenic variants

Affected individualA-II-1A-II-2B-II-1
SexMaleMaleMale
EthnicitySyrianTurkish
ConsanguinousYesYes
Age at last evaluation12 years, 3 months4 years, 5 months9 years, 7 months
Clinical phenotype
Pregnancy
  GestationUnknown38+141+2
  Birth weight (g)Unknown3492 g (0.36 SD)3570 g (−0.41 SD)
  Birth length (cm)Unknown56 cm (2.08 SD)50 cm (−1.37 SD)
  Birth OFC (cm)Unknown34.5 cm (−0.33 SD)34 cm (−1.47 SD)
Growth (last assessment)
  OFC (cm)49.5 cm (−3.10 SD)48 cm (−2.33 SD)48 cm (−3.58 SD)
  Height (cm)125 cm (−3.71 SD)101 cm (−1.66 SD)121 cm (−3.10 SD)
  Weight (kg)26.3 kg (−2.95 SD)13.8 kg (−2.50 SD)19.6 kg (−4.01 SD)
Neurodevelopment
  Motor delay HP:0001270+++
  Speech delay HP:0000750+++
  Fine motor impairment HP:0007010+++
  ID, mild HP:0001256++/−
  ID, severe HP:0010864+
  Hyperactivity HP:0000752+
  Short attention span HP:0000736+++
  Sleep disturbance HP:0002360++
Dysmorphism
  Postnatal microcephaly HP:0005484+++
  Smooth philtrum HP:0000319+++
  Thin upper lip vermilion HP:0000219+++
  Strabismus HP:0000486+
  2–3 toe cutaneous syndactyly HP:0005709++
  High palate HP:0000218+
Brain MRI
  Hypoplasia of the cerebellar vermis HP:0006817n.d.+
  Hypoplasia of the corpus callosum HP:0002079n.d.+
  Delayed myelination HP:0012448n.d.+
 Gastrointestinal features
  Nausea and vomiting HP:0002017+++/–
  Gastro-oesophageal reflux HP:0002020+++
  Failure to thrive HP:0001508+++
ATP9A (NC_000020.1, NM_006045.3, NP_006036.1) genotypes and variant description
gDNAg.50292679G>Ag.50310546C>T
cDNAc.868C>Tc.642+1G>A
RNAn.a.r.547_642del (exon7)
Proteinp.(Arg290*)p.(Ser184Profs*16)
GenotypeHomozygousHomozygous
gnomAD frequencyAbsentAbsent
  • + indicates presence; − indicates absence; +/− means features might be present.

  • HP, Helicobacter pylori; ID, intellectual disability; n.a., not applicable; n.d., not determined; OFC, head circumference.